BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it has enrolled the first subject in its Phase IB clinical trial in which RGN-352 ...
ROCKVILLE, Md., May 29, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, ...
RegeneRx Seeking Strategic Partnership to Address CF in U.S. and Europe BETHESDA, Md., Oct. 1, 2008--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today ...
Pooled Data from Three Phase 3 Clinical Trials in ~1500 Patients Shows Statistically Significant Improvements of Signs and Symptoms of DES ROCKVILLE, Md., May 14, 2021 /PRNewswire/ -- RegeneRx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results